A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis.

Source:http://linkedlifedata.com/resource/pubmed/id/11134430

Download in:

View as

General Info

PMID
11134430